A new market study on the 2022-2028 Ragweed Pollen Allergy Treatment Market with 100+ market data Tables, Pie Chat, and Graphs & Figures spread through Pages and easy to understand detailed analysis. At present, the market is developing its presence. The Research report presents a complete assessment of the Market and contains a future trend, current growth factors, attentive opinions, facts, and industry-validated market data. The report incorporates a broad evaluation of different methods like combinations and acquisitions, thing headways, and investigation and enhancements embraced by observable market pioneers to stay at the front line in the overall market.
Get PDF Brochure with Latest Insights @ https://www.coherentmarketinsights.com/insight/request-pdf/4054
Increasing prevalence of ragweed pollen allergy is driving growth of the global ragweed pollen allergy treatment market. According to the American College of Allergy, Asthma, and Immunology, 2020, there are about 17 species of ragweed in the U.S. The weeds grow in most of the regions in the U.S., usually blooming and producing fine-powder pollen from August to November. The allergies associated with ragweed are treated with antihistamines and other allergy-related medications.
Moreover, the changes in climatic condition and growing pollution are other major factors driving the global ragweed pollen allergy treatment market growth. For instance, according to the Asthma and Allergy Foundation of America (AAFA), around 23 million people in the U.S. have symptoms from ragweed pollen allergy in the late summers. These symptoms can make life depressed for those with allergies, which can also cause asthma symptoms for allergic asthma people.
Global Ragweed Pollen Allergy Treatment Market – Impact Analysis of COVID-19
The global ragweed pollen allergy treatment market growth is affected to some extent by the outbreak of COVID-19 as it is difficult to conduct clinical trials during the pandemic. However, the overall market is witnessing an optimistic growth because of the similarity of symptoms of COVID-19 and ragweed pollen allergy.
The all-inclusive version of the report will include the impact of COVID-19 and the probable changes in the future outlook of the industry, by taking into the account the technological, social, political, and economical parameters.
The global ragweed allergy treatment market is estimated to be valued at US$ 836.9 million in 2020 and is expected to register a CAGR of 4.61% during the forecast period (2020-2027).
Rise in number of clinical trials of therapies for treating ragweed pollen allergy and strategic collaborations are projected to augment the market growth during the forecast period
Key players are highly involved in research & development of advanced drugs and novel therapies. This is expected to foster market growth over the forecast period
For instance, in May 2015, two Austria-based biotech companies, Biomay and VTU Technology, entered a collaborative licensing agreement to produce recombinant allergens. Biomay had formerly managed to produce and deliver a major allergen from ragweed pollen as a recombinant product. Under the agreement terms, VTU Technology will be given royalties on the basis of worldwide sale of recombinant allergens produced by Biomay.
For instance, in September 2018, Genentech’s Xolair received U.S. FDA approval for the treatment of allergies. Xolair is the only biologic approved product for allergic asthma as well as chronic idiopathic urticarial. The product is already approved to treat patients 12 years and older with allergic asthma. According to Genentech, this approval will help in addressing unmet needs of patients and caregivers or parents.
Buy This Report And Get Quick Access( Flat USD 2000 OFF ) – https://www.coherentmarketinsights.com/promo/buynow/4054
Global Ragweed Pollen Allergy Treatment Market – Restraints
The lack of awareness regarding allergy immunotherapy is projected to hinder growth of the global ragweed pollen allergy treatment market. Additionally, side effects associated with allergic immunotherapy is another key factor that is expected to restrict the market growth.
Moreover, the high costs associated with treatment of ragweed pollen allergy are projected to hinder the market growth during the forecast period.
Ragweed Pollen Allergy Treatment Market Report Coverage
|Base Year:||2019||Market Size in 2019:||US$ 836.9 Mn|
|Historical Data for:||2016 to 2019||Forecast Period:||2020 to 2027|
|Forecast Period 2020 to 2027 CAGR:||4.6%||2027 Value Projection:||US$ 1,147.3 Mn|
|Companies covered:||ALK-Abello A/S, ASIT Biotech SA, Anergis SA, Biomay AG, Astellas Pharma Inc., Thermo Fisher Scientific Inc, Siemens Healthcare Private Limited, Omega Diagnostics Group PLC, Stallergenes Greer, bioMerieux SA, Lincoln Diagnostics, Inc, HOB Biotech Group Corp Ltd, HYCOR Biomedical, Inc, Alcon, Hitachi Chemical Diagnostics, Inc, Quest Diagnostics Incorporated, Circassia, Immunomic Therapeutics, Inc, Novartis AG, Japan Tobacco Inc, GlaxoSmithKline plc, REGiMMUNE Co, Ltd, Sanofi, and Merck KGaA.|
|Restraints & Challenges:||
Global Ragweed Pollen Allergy Treatment Market – Regional Analysis
The market in North America accounted for the largest share in the global ragweed pollen allergy treatment in 2019 as it is one of the most common causes of allergies in the region. Moreover, key players are high;ly focused on obtaining product approvals and clinical trials of drugs for the treatment of ragweed pollen allergy which is expected to propel the market growth. For instance, the U.S. Food and Drug Administration (FDA) has recently approved two novel prescription medications, Ragwitek and Grastek, for the treatment of ragweed pollen and grass pollen allergy.
For instance, in April 2020, ALK, a Denmark-based research-driven pharmaceutical company announced the Health Canada approval of ITULATEK SLIT-tablets for the tree pollen allergy treatment. ITULATEKTM is available in Canada and is the fourth once-daily SLIT (Sublingual Allergy Immunotherapy) tablet from ALK. This tablet is indicated as allergy immunotherapy for moderate treatment of allergic rhinitis induced by pollen from alder, birch, or hazel in adults in the age group of 18 to 65 with a clinical history of allergic rhinitis.
Furthermore, the Europe market is also expected to experience significant growth owing to initiatives taken by key players and for treatment of ragweed pollen allergy. For instance, in February 2017, ALK submitted a registration application for ‘Ragweed SLIT-tablet’ in Europe. The tablet has been accepted for review via decentralized procedure by relevant health authorities with Germany being the Reference Member State. The company’s proposed indication is for treatment of patients in the age group of 18 to 65 with ragweed allergic conjunctivitis and/or rhinitis, despite the use of symptom-relieving medication.
Global Ragweed Pollen Allergy Treatment Market – Competitive Landscape
Key players operating in the global ragweed pollen allergy treatment market are ALK-Abello A/S, ASIT Biotech SA, Anergis SA, Biomay AG, and Astellas Pharma Inc., Thermo Fisher Scientific Inc, Siemens Healthcare Private Limited, Omega Diagnostics Group PLC, Stallergenes Greer, bioMerieux SA, Lincoln Diagnostics, Inc, HOB Biotech Group Corp Ltd, HYCOR Biomedical, Inc, Alcon, Hitachi Chemical Diagnostics, Inc, Quest Diagnostics Incorporated, Circassia, Immunomic Therapeutics, Inc, Novartis AG, Japan Tobacco Inc, GlaxoSmithKline plc, REGiMMUNE Co, Ltd, Sanofi, and Merck KGaA.
Get Sample Report with Latest Covid19 Impact Analysis @ https://www.coherentmarketinsights.com/insight/request-sample/4054
Table Of Content
Chapter No. 1 Introduction
1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. USP & Key Offerings
1.2. Key Benefits for Stakehulders
1.3. Target Audience
1.4. Report Scope
Chapter No. 2 Executive Summary
2.1. Key Findings
2.1.1. Top Investment Pockets
184.108.40.206. Market Attractiveness Analysis, By Type
220.127.116.11. Market Attractiveness Analysis, By End Use
18.104.22.168. Market Attractiveness Analysis, By Region
2.2. Market Snapshot
2.3. Global Ragweed Pollen Allergy Treatment Market, 2017 – 2022 (USD Million)
2.4. Insights from Primary Respondents
Chapter No. 3 COVID 19 Impact Analysis
3.1. Impact Assessment of COVID-19 Pandemic, By Region
3.1.1. North America
3.1.3. Asia Pacific
3.1.4. Latin America
3.1.5. The Middle-East and Africa
Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defense, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027